Circadian Technologies Ltd. (CKDXY: OTCQX International) | Phase 1a clinical oncology trial with VGX-100 successfully completes patient enrolment

Phase 1a clinical oncology trial with VGX-100 successfully completes patient enrolment

Oct 17, 2013

OTC Disclosure News Service

South Yarra, Victoria, Australia

This release includes additional documents. Select the link(s) below to view.

20131017 ASX October 18_Ceres_P1a_Press Release_Final.pdf

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Article source: http://www.otcmarkets.com/stock/CKDXY/news?id=69975

Leave a Reply

WP Facebook Auto Publish Powered By : XYZScripts.com
Bunk Beds